|
7
|
41
|
3bpsE |
Pcsk9:egf-a complex |
|
25
|
124
|
3bt2A |
Structure of urokinase receptor, urokinase and vitronectin complex |
|
17
|
85
|
3bt4A |
Crystal structure analysis of amfpi-1, fungal protease inhibitor from antheraea mylitta |
|
66
|
342
|
3bt6A |
Crystal structure of influenza b virus hemagglutinin |
|
15
|
111
|
3bukA |
Crystal structure of the neurotrophin-3 and p75ntr symmetrical complex |
|
17
|
104
|
3bk3A |
Crystal structure of the complex of bmp-2 and the first von willebrand domain type c of crossveinless-2 |
|
23
|
159
|
3bukC |
Crystal structure of the neurotrophin-3 and p75ntr symmetrical complex |
|
16
|
106
|
3bmpA |
Human bone morphogenetic protein-2 (bmp-2) |
|
4
|
46
|
3bg4D |
The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor |
|
148
|
607
|
3be1A |
Dual specific bh1 fab in complex with the extracellular domain of her2/erbb-2 |
|
15
|
95
|
3bdyV |
Dual specific bh1 fab in complex with vegf |
|
17
|
116
|
3b4vA |
X-ray structure of activin in complex with fstl3 |
|
40
|
375
|
3b2vA |
Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the fab fragment of imc-11f8 |
|
146
|
510
|
3avsA |
Catalytic fragment of utx/kdm6a bound with n-oxyalylglycine, and ni(ii) |
|
144
|
510
|
3avrA |
Catalytic fragment of utx/kdm6a bound with histone h3k27me3 peptide, n-oxyalylglycine, and ni(ii) |
|
92
|
395
|
3asiA |
Alpha-neurexin-1 ectodomain fragment; lns5-egf3-lns6 |
|
25
|
162
|
3alqR |
Crystal structure of tnf-tnfr2 complex |
|
64
|
321
|
3al4A |
Crystal structure of the swine-origin a (h1n1)-2009 influenza a virus hemagglutinin (ha) reveals similar antigenicity to that of the 1918 pandemic virus |
|
8
|
52
|
2zp9C |
The nature of the trap:anti-trap complex |
|
51
|
163
|
2zycA |
Crystal structure of peptidoglycan hydrolase from sphingomonas sp. a1 |
|
97
|
430
|
2znhA |
Crystal structure of a domain-swapped serpin dimer |
|
8
|
53
|
2zp8E |
The nature of the trap:anti-trap complex |
|
33
|
241
|
2ygqA |
Wif domain-epidermal growth factor (egf)-like domains 1-3 of human wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine |
|
4
|
74
|
2yraA |
Solution structure of the zinc finger domains (1-87) from human f-box only protein |
|
30
|
180
|
2ygpA |
Wif domain-egf-like domain 1 met77trp of human wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine |
|
31
|
180
|
2ygoA |
Wif domain-egf-like domain 1 of human wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine |
|
165
|
489
|
2y2oA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (eo9) |
|
143
|
461
|
2xueA |
Crystal structure of jmjd3 |
|
22
|
123
|
2ybyA |
Structure of domains 6 and 7 of the mouse complement regulator factor h |
|
173
|
732
|
2xwbF |
Crystal structure of complement c3b in complex with factors b and d |
|
12
|
52
|
2y7xB |
The discovery of potent and long-acting oral factor xa inhibitors with tetrahydroisoquinoline and benzazepine p4 motifs |
|
163
|
732
|
2xwjI |
Crystal structure of complement c3b in complex with factor b |
|
157
|
489
|
2y2pA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (z10) |
|
91
|
412
|
2y8rA |
Crystal structure of apo ama1 mutant (tyr230ala) from toxoplasma gondii |
|
13
|
52
|
2y82B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
12
|
54
|
2y5gL |
Factor xa - cation inhibitor complex |
|
164
|
489
|
2y2qA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (z06) |
|
163
|
489
|
2y2mA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (e08) |
|
165
|
486
|
2y2gA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (a01) |
|
12
|
54
|
2y5fL |
Factor xa - cation inhibitor complex |
|
159
|
487
|
2y2iA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (za3) |
|
12
|
52
|
2y81B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
159
|
488
|
2y2jA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (za4) |
|
162
|
489
|
2y2lA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (e06) |
|
160
|
488
|
2y2nA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (e07) |
|
97
|
411
|
2y8sA |
Co-structure of an ama1 mutant (y230a) with a surface exposed region of ron2 from toxoplasma gondii |
|
163
|
488
|
2y2kA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (za5) |
|
159
|
487
|
2y2hA |
Penicillin-binding protein 1b (pbp-1b) in complex with an alkyl boronate (za2) |
|
16
|
104
|
2xv7A |
Crystal structure of vascular endothelial growth factor d |
|
12
|
52
|
2y7zB |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
